Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

New medications could improve treatment for severe alopecia areata in Australia.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Advanced human skin models improve drug development and could replace animal testing.

A Brazilian male with IFAP syndrome has a unique genetic variant causing his condition.

Key proteins and potential drugs for treating alopecia areata were identified.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

The humanized AA mouse model is better for testing new alopecia areata treatments.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Ayurvedic treatment significantly improved hair regrowth in a child with Alopecia Universalis.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.